期刊文献+

pAdKDR/CD/TK自杀基因系统对大肠癌SW480细胞体外杀伤作用的实验研究 被引量:2

Killing effect of KDR promoter driving double suicide gene on human colorectal cancer SW480 cells in vitro
原文传递
导出
摘要 目的研究腺病毒介导的KDR/CD/TK双自杀基因系统对大肠癌SW480细胞的杀伤作用。方法构建pAdKDR/CD/TK重组腺病毒,采用不同感染复数(MOI)的重组腺病毒感染大肠癌SW480细胞、ECV304细胞及LS174T细胞,再加入不同浓度前药(GCV、5-FC)培养后,以MTT法检测细胞生长抑制率,观察重组腺病毒联合GCV和5-FC对大肠癌SW480细胞、ECV304细胞和LS174T细胞的杀伤作用,了解前药GCV、5-FC、GCV/5-FC对3种细胞的杀伤作用及KDR启动子的靶向杀伤作用。结果 pAdKDR/CD/TK重组腺病毒对3种细胞具有相似的感染率,感染腺病毒的3种细胞中除LS174T细胞外,均检测到目的基因的表达。当转基因细胞的比率为50%时,SW480和ECV304细胞分别有(31.3±5.64)%、(33.5±5.4)%的存活,而LS174T细胞存活率仍为(98.1±0.95)%(P均<0.01)。单用GCV浓度为80μg/ml时,SW480细胞、ECV304细胞、LS174T细胞的生存率分别为(45.6±6.5)%、(45.9±5.4)%、(99.5±4.7)%,单用5-FC浓度为1000μg/ml时,三者生存率分别为(40.4±5.8)%、(45.3±4.7)%、(97.0±6.2)%,联合用药(80μg/ml+1000μg/ml)时,三者生存率分别为(20.5±0.46)%、(25.6±1.33)%、(97.3±3.96)%。联合用药分别与GCV及5-FC单独用药生存率比较,差异均有统计学意义(P均<0.05)。提示单独应用GCV及5-FC对SW480细胞、ECV304细胞有较强的杀伤作用,联合用药效果更佳。结论含KDR启动子的融合基因,具有选择性杀伤作用。前药GCV、5-FC对转染融合基因的大肠癌SW480细胞具有体外抑制作用,且有较强的旁观者效应。 Objective To investigate the killing effect of adenovirus vector containing KDR promoter driving double suicide genes on colorectal SW480 cells in vitro.Methods The pAdKDR/TK/CD re-compound adenovirus vector was constructed and the SW480 colorectal cancer cells,ECV304 cells and LS174T cells were transferred by pAdKDR/TK/CD re-compound adenovirus of different multiplicity of infection(MOI).Then the pro-drugs (GCV,5-FC) of different concentration were added in them for co-culturing.The cell growth inhibiting rate was detected by MTT method for observing killing effect of pro-drug and understanding the target killing effect of KDR promoter.Results The pAdKDR/TK/CD re-compound adenovirus had similar transferring efficiency to SW480,ECV304 and LS174T cells.The expres sions of target gene in transferred cells were all detected besides LS174T cells.When the ratio of transferred cells was 50%,the survival rates were (31.3±5.64)% for SW480 cells,(33.5±35.4)% for ECV304 cells and (98.1±0.95)% for LS174T cells.The former two did not have significant difference (P〉0.05),but they were all significantly different from the latter (all P〈0.01).When the concentration of the GCV was 80 μg/ml,the survival rates of SW480 cells,ECV304 cells and LS174T cells were (45.6±6.5)%,(45.9±5.4)% and (99.5±4.7)%,respectively;when the concentration of 5-FC was 1 000 μg/ml,the survival rates of three kind cells were (40.4±5.8)%,(45.3±4.7)% and (97.0±6.2)%,respectively;when combining GCV with 5-FC(80/1 000 μg/ml),the survival rates of three kind cells were(20.5±0.5)%,(25.6±1.3)% and (97.3±4.0)%,respectively.Compared with GCV or 5-FC alone,the survival rates of SW480 and ECV304 cells were obviously lower(all P〈0.05)in their combining application.Conclusions The fusion gene built up with KDR promoter has selective killing effect.The prodrugs GCV and 5-FC have killing effect on SW480 cells transfected by fusion gene in vitro,and have stronger bystander effect.
出处 《中国临床研究》 CAS 2011年第2期91-95,共5页 Chinese Journal of Clinical Research
关键词 自杀基因 CD TK 含激酶插入结构域的受体 杀伤作用 旁观者效应 大肠癌 Suicide gene,CD,TK; Kinase domain insert containing receptor; Killing effect; Bystander effect; Colorectal cancer;
  • 相关文献

参考文献15

  • 1Bocci G, Man S, Green SK, et al. Increased plasma vascular endo- thelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies[ J]. Cancer Res,2004,64 ( 18 ) :6616 - 6625.
  • 2Heidenreich R, Machein M, Nicolans A, et al. Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants[ J]. Int J Cancer,2004,111 ( 3 ) :348 - 357.
  • 3Lillo R, Ramirez M, Alvaerz A, et al. Efficient and nontoxic adenovi- ral purging method for autologous transplantation in breast cancer patients [ J ]. Cancer Res,2002,62 ( 17 ) :5013 - 5018.
  • 4Veldwijk MR,Fruehauf S,Sehiedlmeier B,et al. Differential expression of a recombinant adeno-associated virus 2 vector in hurrah CD34 +cells and breast eanoer cells[J]. Cancer Gene Ther,2000,7(4) :597 -604.
  • 5Suhardja A, Hoffman H. Role of growth factors and their receptors in proliferation of microvascular endothelial cells [ J ]. Microsc Res Tech, 2003,60( 1 ) :70 - 75.
  • 6Underiner TL, Ruggeri B,Gingrich DE. Development of vascular endothe- lial growth factor receptor (VEGFR) kinase inhibitors as anti-angiogenic agents in cancer therapy[ J ]. Curr Meal Chem,2004,11 ( 6 ) :731 - 745.
  • 7Folkman J. What is the evidence that tumors are angiogenesis dependent?[ J]. J Natl Cancer Inst,1990,82( 1 ) :4 -6.
  • 8Kraemer-Pecore CM,Lecomte J-T,Desjarlais JR,et al. A de novo rede- sign of the WW domain( J]. Protein Sci ,2003,12(10) :2194 -2205.
  • 9Tsuji T,Miyazaki M,Sakaguchi M,et al. A REIC gene shows down- regulation in human immortalized cells and human tumor-derived cell lines [ J ]. Biochem Biophys Res Commun, 2000,268 ( 1 ) :20.
  • 10Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors[ J ]. Science, 1992,256 ( 5063 ) : 1550 - 1552.

同被引文献36

  • 1Guo, Kemphues KJ. par-l, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed [J]. Cell, 1995, 81 (4) : 611-620.
  • 2Fuks F. DNA methylation and histone modification: teaming up to silence genes [J]. Curr Opin Genet Dev, 2005, 15 (5) : 490-495.
  • 3Yang J, Sun M, Zhang A, et al. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells [J]. World J Surg Oncol, 2011, 9: 117.
  • 4Hur K, Cejas P, Feliu J, et al. Hypomethylation of long interspersed nuclear element- 1 (LINE- 1 ) leads to activation of proto-oncogenes in human colorectal cancer metastasis [J]. Gut, 2013, May 23. [Epub ahead of print].
  • 5Noaki R, Kawahara H, Watanabe K, et al. Serum p53 antibody is a useful tumor marker of early colorectal cancer [J]. Int Surg, 2010, 95(4): 287-292.
  • 6He ZY, Shi CB, Wen H, et al. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin [J]. Cancer Invest, 2011, 29(3): 208-213.
  • 7Lazaro M, et al. p16 gene methylation in colorectal cancer patients with long-term follow-up [J]. Rev Esp Enferm Dig, 2012, 104(3): 111-117.
  • 8Nakayama G, Kodera Y, Ohashi N, et al. pl6INK4a methylation in serum as a follow-up marker for recurrence of colorectal cancer [ J ]. Anticancer Res, 2011, 31 (5) : 1643- 1646.
  • 9Parney IF, Chang LJ. Cancer immunogene therapy: a review [J]. J Biomed Sci, 2003, 10(1): 37-43.
  • 10He X, Li W, Wang Y, et al. Inhibition of colon tumor growth by IL-15 immunogene therapy [J]. Mol Med Rep, 2012, 5(1): 96-102.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部